Li Qingxin, Kang CongBao
Guangdong Provincial Engineering Laboratory of Biomass High Value Utilization, Institute of Biological and Medical Engineering, Guangdong Academy of Sciences, Guangzhou 510316, China.
Experimental Drug Development Centre (EDDC), Agency for Science, Technology and Research (A*STAR), 10 Biopolis Road, #05-01, Singapore 138670, Singapore.
Molecules. 2024 Dec 5;29(23):5748. doi: 10.3390/molecules29235748.
Fragment-based drug discovery is a powerful approach in drug discovery, applicable to a wide range of targets. This method enables the discovery of potent compounds that can modulate target functions, starting from fragment compounds that bind weakly to the targets. While biochemical, biophysical, and cell-based assays are commonly used to identify fragments, F-NMR spectroscopy has emerged as a powerful tool for exploring interactions between biomolecules and ligands. Because fluorine atoms are not naturally present in biological systems, F-NMR serves as a sensitive method for fragment screening against diverse targets. Herein, we reviewed the applications of F-NMR in fragment screening, highlighting its effectiveness in identifying fragments that bind weakly to various targets such as proteins and RNA. The accumulated evidence suggests that F-NMR will continue to be a crucial tool in drug discovery.
基于片段的药物发现是药物研发中的一种强大方法,适用于广泛的靶点。该方法能够从与靶点弱结合的片段化合物出发,发现可调节靶点功能的强效化合物。虽然生化、生物物理和基于细胞的检测方法常用于鉴定片段,但F-核磁共振光谱已成为探索生物分子与配体之间相互作用的强大工具。由于氟原子并非天然存在于生物系统中,F-核磁共振光谱是针对多种靶点进行片段筛选的灵敏方法。在此,我们综述了F-核磁共振光谱在片段筛选中的应用,突出了其在鉴定与蛋白质和RNA等各种靶点弱结合的片段方面的有效性。积累的证据表明,F-核磁共振光谱将继续成为药物研发中的关键工具。